Labcorp Launches FDA-Approved PTEN Companion Diagnostic for Prostate Cancer
PR Newswire•04/08/2026•07:00 ET
0
Whiz Insights
Labcorp Launches FDA-Approved PTEN Companion Diagnostic for Prostate Cancer
First FDA-approved IHC assay identifies patients who may be eligible for combination treatment with TRUQAP® (capivasertib)
Get started
Create a free account to read the full story.